1IC
ALBO

1919 Investment Counsel’s Albireo Pharma Inc ALBO Stock Holding History

1919 Investment Counsel’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-83
Closed -$8K – 1031
2013
Q3 		$8K Hold
83
– – ﹤0.01% 892
2013
Q2 		$11K Buy
+83
New +$8.64K ﹤0.01% 848

Other funds holding ALBO

William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

1919 Investment Counsel's ALBO Position: Q4 2013 in Review

1919 Investment Counsel sold out of Albireo Pharma Inc (ALBO) in Q4 2013, closing a stake of 83 shares — an estimated $8K sold.

1919 Investment Counsel first reported a position in ALBO in Q2 2013 and held it in 2 quarters. The position peaked at $11K in Q2 2013. 41 funds tracked by Wall St. Rank hold ALBO as of Q4 2013.

  • 1919 Investment Counsel reported no remaining Albireo Pharma Inc position as of Q4 2013 after selling out during the quarter.
  • 1919 Investment Counsel sold 83 Albireo Pharma Inc shares in Q4 2013, an estimated $8K.
  • 1919 Investment Counsel first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 2 quarters.
  • 1919 Investment Counsel's Albireo Pharma Inc position peaked at $11K in Q2 2013.
  • 41 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2013.

Based on 1919 Investment Counsel's 13F filing for Q4 2013, filed 14 Feb 2014.